title: The EORTC Phase II study of iproplatin in advanced osteogenic sarcoma.
authors.forename: A
authors.initials: A
authors.lastname: Pawinski
authors.forename: D
authors.initials: D
authors.lastname: Crowther
authors.forename: H J
authors.initials: HJ
authors.lastname: Keizer
authors.forename: P A
authors.initials: PA
authors.lastname: Voûte
authors.forename: R
authors.initials: R
authors.lastname: Somers
authors.forename: M
authors.initials: M
authors.lastname: van Glabbeke
authors.forename: M A
authors.initials: MA
authors.lastname: Lentz
authors.forename: A T
authors.initials: AT
authors.lastname: van Oosterom
mesh_terms: D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000627:therapeutic use*; D012516:Osteosarcoma / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; C023359:iproplatin